Blood Cancer Talks

In this episode, we dissect the management of newly diagnosed Ph-negative Acute Lymphoblastic Leukemia with Dr. Anjali Advani.

Show Notes

Key papers discussed in the show:
1.     Pediatric regimen for older adolescents and young adults with ALL: CALGB 10403
2.     Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: C19802
3.     Rituximab in B-ALL
4.     A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients with Newly Diagnosed Philadelphia Chromosome–Negative B-Cell Acute Lymphoblastic Leukemia: SWOG 1318
5.     Blinatumomab for MRD in adults with B-ALL
6.     Ph-like ALL

What is Blood Cancer Talks?

This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.
Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston
Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk